Jade Biosciences, Inc.

US$15.07As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:JBIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM 53.78%
Mkt cap US$958.4M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$16
7.44%
(30.07%)
Hold 6|4|8|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.21
0.22
0.21
0.23
16.93%
9.24%
4.05%
6.51%
Revenue$M
81.51
84.51
82.30
81.36
5.45%
5.29%
3.77%
1.37%
Peers (US$958.4M)
Cap (US$)
PE
955.8M
3.800x
Capital
TTM
5Y
10Y
Leveragex
12.56
0.390
0.388
EBIT/Intx
0.854
0.093
0.099
Own earn%
(24.00)
185.91
180.36
Sh yield%
23.15
11.66
13.87
Owners
Insiders/Inst%
5.86
84.97
Short interest%
4.73
SBC / revenue%
1.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
13–19
$1 testx
—
Incr. ROIC%
8